Back to search

Article

Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) study

2018-10-01

Abstract excerpt

Background: A noninvasive cfDNA blood test detecting multiple high-mortality cancers at early stages when treatment is more likely effective could decrease cancer mortality. CCGA (NCT02889978) is a prospective multi-center observational study to develop a plasma cfDNA-based multi-cancer detection assay.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8fbf2e97-c097-56ef-921a-af9d50ece60c
DOI
10.1093/annonc/mdy269.048
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) studyDOI 10.1093/annonc/mdy269.048
Select a neighboring publication to make it the new centre.